Linaclotide, a guanylate cyclase C receptor agonist, has shown promising efficacy as a treatment for chronic constipation in a phase IIb, double-blinded, placebo-controlled, dose-ranging trial.

Medicare Part D prescription drug plans and Medicare Advantage plans that include prescription drug coverage typically cover the cost of Linzess. However, as private insurers provide Medicare Part ...